Seeing the words “positive surgical margin” on your pathology report can sound worrying, but it does not automatically mean cancer remains in your body. It means cancer cells were found at the edge of the tissue removed during surgery and can increase your risk of recurrence.
Your specialist will look at your postoperative PSA alongside your Grade Group, tumour stage, lymph nodes and margin details. You may only need PSA monitoring, although radiotherapy may be considered if your results suggest a higher risk of recurrence.
What Does a Surgical Margin Mean on Your Pathology Report?
Your surgical margin is the inked surgical surface or cut edge of the tissue removed during your prostatectomy. If no cancer cells reach this surface, the margin is negative; if cancer cells reach the inked surgical surface, the margin is positive.
Your pathologist checks this under a microscope after surgery. A positive margin can increase your recurrence risk, but it does not automatically mean cancer remains in your body.
What Does a Positive Surgical Margin Actually Mean?
A positive margin means tumour cells are touching the inked surgical surface of the removed specimen. It increases your recurrence risk but cannot tell your doctor whether viable cancer definitely remains.
Your postoperative PSA provides important additional information. Your specialist will consider it alongside your pathology when deciding whether monitoring or further treatment is appropriate.
Does a Positive Margin Mean Cancer Was Definitely Left Behind?
No. A positive margin increases the possibility that microscopic cancer remains, but the pathology finding alone cannot prove this.
If your PSA becomes undetectable and remains stable, monitoring may be appropriate. If it remains detectable or later rises, your specialist can discuss whether further assessment or treatment is needed.
Is a Positive Margin the Same as Cancer Growing Outside the Prostate?
No. A positive margin means cancer cells reach the cut edge of the tissue removed during your surgery. Cancer growing outside the prostate, called extraprostatic extension, is a separate finding.
You can therefore have a positive margin without cancer growing outside the prostate. Your pathology report considers both findings, helping your specialist understand your risk and decide what follow-up you need.
Why Can a Positive Margin Occur During Robotic Prostatectomy?
Your prostate lies close to structures such as the urinary sphincter and neurovascular bundles, which can make surgical dissection complex. A positive margin can occur when cancer lies very close to the surgical surface.
Microscopic cancer may also extend farther than can be seen during surgery. This does not automatically mean your surgeon made a mistake.
Where Can Positive Surgical Margins Occur?
A positive margin can occur at different parts of your prostate, such as the apex, base, bladder neck or sides near the nerves. Your pathology report may tell you exactly where cancer reached the edge.
The location helps your doctor understand your results, but your margin length, cancer grade, stage and postoperative PSA are also important when assessing your risk.
Does the Length of a Positive Margin Matter?
Yes. A very small positive margin can have a different risk from a longer or multiple positive margins. Your pathology report may give the margin length in millimetres.
Your doctor will also consider your cancer grade, stage and PSA. A short positive margin with an undetectable PSA can give you a different outlook from a longer margin with more aggressive cancer.
Evidence Note
A 2024 systematic review and meta-analysis included 31 studies involving 50,028 patients after radical prostatectomy. Longer positive surgical margins, multiple positive margins, higher-grade cancer at the margin and more advanced pathological stage were all associated with a greater risk of biochemical recurrence.
The Royal College of Pathologists also recommends recording the location and extent of positive margins and uses a 3 mm cut-off for margin extent in its current prostatectomy dataset. These findings help refine risk assessment, but they cannot predict with certainty whether an individual patient will experience recurrence.
Does the Grade of Cancer at the Margin Matter?
Yes. The grade of cancer found at your positive margin can affect your risk. A short positive margin containing a lower Gleason grade pattern may carry a different recurrence risk from a margin containing a higher-grade cancer pattern.
Your specialist will also consider your overall Grade Group, tumour stage, margin length and PSA. Looking at all these results together gives you a clearer picture of your risk and whether you need further treatment.
What Can Change the Significance of a Positive Surgical Margin?
Not every positive surgical margin carries the same risk. Several features of your pathology and postoperative PSA can change what the finding means for you.
| Finding | Why It Matters |
| Margin length | Longer margin involvement has generally been associated with a higher risk of PSA recurrence |
| Single or multiple margins | Multifocal positive margins can indicate a greater recurrence risk than a single focal margin |
| Cancer grade at the margin | Higher-grade cancer patterns at the margin are associated with less favourable outcomes |
| Pathological stage | Extraprostatic extension or seminal-vesicle invasion adds important risk information independently of margin status |
| Lymph-node findings | Cancer in regional lymph nodes changes the overall postoperative risk and treatment strategy |
| Postoperative PSA | An undetectable PSA is reassuring, while persistent or subsequently rising PSA requires closer assessment |
No single margin feature determines what will happen next. Your specialist interprets the complete pathology and PSA pattern together.
Does a Positive Margin Mean Your Robotic Surgery Failed?
No. A positive margin does not mean your robotic surgery failed. It means cancer cells reached the edge of the tissue removed, which can increase your risk of recurrence.
If your PSA becomes undetectable and stays low, you may only need regular monitoring. Your specialist will consider your PSA and pathology results before deciding whether you need any further treatment.
What Should Happen to Your PSA After Surgery?
After your prostate is removed, your PSA should fall to a very low or undetectable level. If it becomes undetectable, that is reassuring even if you had a positive margin.
If your PSA stays detectable or starts rising later, your specialist may investigate further. Your PSA trend, together with your pathology results, helps your doctor decide whether you need further treatment.
What If Your PSA Is Undetectable Despite a Positive Margin?
If your PSA becomes undetectable after surgery, this is reassuring even if you have a positive margin. You may not need immediate treatment, but regular follow-up remains important.
- Reassuring PSA Result: There is no measurable PSA evidence of cancer activity at that time.
- Continued Monitoring: You will still need regular PSA tests.
- Pathology Matters: Your Grade Group, stage, lymph nodes and margin details affect your overall risk.
- Further Treatment: Radiotherapy may be considered if your PSA later becomes detectable or rises.
An undetectable PSA does not remove the need for follow-up. Your specialist will monitor your PSA and discuss further treatment only if your results suggest it is needed.
What If PSA Remains Detectable After Surgery?
If your PSA stays detectable after surgery, your doctor may want to investigate further. This can sometimes indicate that prostate cancer cells remain, although a positive margin does not prove that the margin is causing the PSA.
Your specialist will look at your PSA level, trend, pathology and any relevant imaging to understand what may be happening. PSA that never becomes undetectable after surgery is generally considered differently from PSA that first falls to an undetectable level and then rises later, so the timing and pattern of your results are important when planning further treatment.
What Is Biochemical Recurrence After Prostatectomy?
Biochemical recurrence refers to a confirmed rise in PSA after prostatectomy, although the exact PSA threshold used to define recurrence can vary between guidelines and clinical settings. You may feel completely well because PSA can detect possible cancer activity before you notice any symptoms.
A positive margin can increase your risk of recurrence, but it does not mean recurrence will definitely happen. Your specialist will look at your PSA pattern and other results to decide whether you need monitoring or further treatment.
How Does PSA Doubling Time Affect the Decision?
Your PSA doubling time shows how quickly your PSA is increasing. A slow rise can mean something different from a PSA that doubles within a few months.
Your specialist will look at this alongside your pathology, Grade Group, stage and margin status. A shorter PSA doubling time can be associated with a higher risk of disease progression and may prompt closer assessment and earlier discussion of further treatment.
Will You Need a PSMA PET/CT Scan?
You may not need a PSMA PET/CT if your PSA is undetectable. Your doctor may consider it if your PSA starts rising and the scan could help find where any recurrence is located.
The scan may show whether cancer is in the prostate bed, pelvic lymph nodes or elsewhere. Your specialist will decide if it is useful for you based on your PSA and whether the result would change your treatment.
Does a Positive Margin Mean You Need Immediate Radiotherapy?
Not usually. A positive margin alone does not automatically mean you need radiotherapy straight away.
Your doctor will look at your PSA, Grade Group, tumour stage and other pathology results. If your PSA is undetectable, you may be monitored closely, with radiotherapy considered if your PSA later starts to rise.
Research Insight
Long-term results from the RADICALS-RT trial followed 1,396 patients at increased risk of recurrence after radical prostatectomy, including people with positive surgical margins. At a median follow-up of 7.8 years, routine adjuvant radiotherapy did not significantly improve freedom from distant metastasis or overall survival compared with an observation policy using salvage radiotherapy if PSA failure developed.
Adjuvant radiotherapy was also associated with more urinary and bowel morbidity. These results support PSA monitoring after surgery for many patients and the use of salvage radiotherapy when clinically indicated rather than routine immediate radiotherapy solely because a surgical margin is positive.
What Is Salvage Radiotherapy?
Salvage radiotherapy is treatment given after prostate surgery when your PSA suggests that prostate cancer may still be present or has returned. It usually targets the prostate bed, where the prostate was previously located.
If your PSA starts rising, your specialist may discuss salvage radiotherapy, sometimes with hormone therapy. A positive margin can make local recurrence more likely, but your PSA, pathology and scans will help decide whether this treatment is right for you.
Can Hormone Therapy Be Needed as Well?
In selected patients, hormone therapy may be added to salvage radiotherapy when clinical and pathological features suggest a higher risk of recurrence. Your PSA, Grade Group, stage and lymph-node results will help your specialist decide whether it could benefit you.
Hormone therapy can cause side effects such as hot flushes, tiredness and reduced sexual desire. Your oncologist should explain why you may need it and how long you might take it.
UK Guidance Note
NICE specifically advises against routine immediate postoperative radiotherapy after radical prostatectomy, even for people with positive surgical margins, outside a clinical trial. PSA should be checked no earlier than six weeks after radical treatment, at least every six months for the first two years and then at least annually.
If biochemical relapse develops after radical prostatectomy without known metastases, NICE recommends prostate-bed radiotherapy. Current European guidance similarly supports early salvage radiotherapy for men with consecutive PSA rises and advises that, once salvage treatment has been chosen, it should not be unnecessarily delayed while waiting for a higher PSA threshold.
What Should You Ask About a Positive Surgical Margin?
Ask your specialist where the positive margin is, how large it is and whether it contains higher-grade cancer. You can also ask whether the margin is in one area or several.
You should then ask about your PSA, Grade Group, tumour stage and lymph-node results. Most importantly, ask whether your results support monitoring or whether you may benefit from further treatment.
Myth vs Fact
| Myth | Fact |
| A positive surgical margin proves that prostate cancer was left behind. | A positive margin means tumour cells reach the inked surgical surface. It increases recurrence risk but does not prove that viable cancer remains in your body. |
| A positive margin means your robotic prostate surgery failed. | Margin status is one pathological risk factor. Many men with positive margins achieve an undetectable PSA and may never require additional treatment. |
| A positive margin means the cancer had definitely grown outside the prostate. | Margin status and extraprostatic extension are separate findings. A positive margin can occur with or without cancer extending beyond the prostate. |
| Every positive margin has the same recurrence risk. | Margin length, multifocality, cancer grade at the margin, pathological stage and postoperative PSA can all influence risk. |
| A positive margin means you need radiotherapy immediately. | Current NICE guidance does not recommend routine immediate postoperative radiotherapy solely because a margin is positive. PSA-guided salvage treatment is appropriate for many patients. |
| An undetectable PSA means follow-up is no longer necessary. | An undetectable PSA is reassuring, but continued PSA monitoring is important because recurrence can occur later. |
Key Takeaways
- A positive surgical margin means prostate cancer cells reach the inked surgical surface of the removed specimen; it does not prove that cancer remains in your body.
- Margin length, number of positive areas and cancer grade at the margin can provide additional information about recurrence risk.
- A positive margin is separate from extraprostatic extension and should not be used by itself to determine pathological stage.
- Postoperative PSA is central to deciding what happens next; an undetectable PSA is reassuring, while persistent or later rising PSA needs further assessment.
- Current UK guidance does not recommend routine immediate radiotherapy solely because a surgical margin is positive.
- Early salvage radiotherapy can be considered if PSA begins to rise, with hormone therapy added in selected higher-risk cases.
Frequently Asked Questions
1. What Does a Positive Surgical Margin Mean After Robotic Prostate Surgery?
A positive surgical margin means cancer cells were found at the edge of the tissue removed during your surgery. It can increase your risk of recurrence, but it does not prove that cancer remains in your body.
2. Does a Positive Surgical Margin Mean Your Surgery Failed?
No. A positive margin does not mean your robotic prostate surgery failed. Your specialist will consider your pathology results and postoperative PSA to understand your individual risk.
3. Does a Positive Margin Mean Cancer Was Left Behind?
Not necessarily. Cancer cells at the surgical margin increase your recurrence risk, but this does not prove that residual cancer remains in your body.
4. Does the Location of Your Positive Margin Matter?
Yes. Your pathology report may show whether the margin is at the apex, base, bladder neck or another area. Your specialist will also consider the margin length, Grade Group, stage and PSA.
5. Does the Length of a Positive Surgical Margin Matter?
Yes. A shorter positive margin may carry a different risk from a longer or multiple positive margins. Your specialist will assess the margin length alongside your other pathology findings and PSA.
6. What If Your PSA Is Undetectable Despite a Positive Margin?
An undetectable PSA after surgery is reassuring, even if you have a positive margin. You may only need regular PSA monitoring unless other findings suggest a higher risk.
7. What If Your PSA Remains Detectable After Surgery?
A detectable PSA may lead your specialist to investigate whether cancer cells remain. Depending on your results, you may need further imaging, closer monitoring or treatment such as salvage radiotherapy.
8. Will You Automatically Need Radiotherapy With a Positive Margin?
No. A positive margin alone does not automatically mean you need immediate radiotherapy. Your specialist will consider your PSA, Grade Group, stage, margin details and other risk factors.
9. Can You Need Hormone Therapy After a Positive Surgical Margin?
You may need hormone therapy if your overall risk of recurrence is higher, particularly when salvage radiotherapy is being considered. Your specialist will decide based on your individual results.
10. What Should You Ask Your Specialist About a Positive Margin?
Ask where your positive margin is, how long it is and what grade of cancer was found there. You should also ask how your margin relates to your PSA, overall pathology and need for further treatment.
Final Thoughts: Understanding a Positive Surgical Margin After Robotic Prostate Surgery
A positive surgical margin can increase your risk of prostate cancer returning, but it does not automatically mean that cancer remains in your body or that you need immediate further treatment. Your postoperative PSA, Grade Group, tumour stage, lymph-node results and details of the margin will help your specialist understand your individual risk and decide whether monitoring or additional treatment is appropriate.
If you have questions after robotic prostate surgery in London, our team at Prostate Clinic London can help you understand your pathology results, PSA follow-up and whether any further treatment may need to be discussed.
References:
- National Institute for Health and Care Excellence (NICE) (2019, updated 2021) Prostate cancer: diagnosis and management. NICE guideline NG131. Published 9 May 2019; last updated 15 December 2021. Available at: https://www.nice.org.uk/guidance/ng131
- The Royal College of Pathologists (2024) G084 Dataset for histopathology reports for prostatic carcinoma. October 2024. Available at: https://www.rcpath.org/resourceLibrary/g084-dataset-for-histopathology-reports-for-prostatic-carcinoma.html
- Guo, H., Zhang, L., Shao, Y., An, K., Hu, C., Liang, X. and Wang, D. (2024) ‘The impact of positive surgical margin parameters and pathological stage on biochemical recurrence after radical prostatectomy: a systematic review and meta-analysis’, PLOS ONE, 19(7), article e0301653. Available at: https://pubmed.ncbi.nlm.nih.gov/38990870
- John, A., Lim, A., Catterwell, R., Selth, L. and O’Callaghan, M. (2023) ‘Length of positive surgical margins after radical prostatectomy: does size matter? A systematic review and meta-analysis’, Prostate Cancer and Prostatic Diseases, 26(4), pp. 673–680. Available at: https://pubmed.ncbi.nlm.nih.gov/36859711
- Parker, C.C., Petersen, P.M., Cook, A.D. et al. (2024) ‘Timing of radiotherapy (RT) after radical prostatectomy (RP): long-term outcomes in the RADICALS-RT trial (NCT00541047)’, Annals of Oncology, 35(7), pp. 656–666. Available at: https://pubmed.ncbi.nlm.nih.gov/38583574
- European Association of Urology (EAU) (2026) EAU Guidelines on Prostate Cancer: Treatment. Available at: https://uroweb.org/guidelines/prostate-cancer/chapter/treatment
- Carrie, C., Magné, N., Burban-Provost, P. et al. (2019) ‘Short-term androgen deprivation therapy combined with radiotherapy as salvage treatment after radical prostatectomy for prostate cancer (GETUG-AFU 16): a 112-month follow-up of a phase 3, randomised trial’, The Lancet Oncology, 20(12), pp. 1740–1749. Available at: https://pubmed.ncbi.nlm.nih.gov/31629656